Highlights
NASDAQ: BPTH       Bio-Path Holdings
Last Price Today's Change   Day's Range   Trading Volume
4.08   -0.63 (13.38%)  3.97 - 4.49  777,000

Overview

 
Avg Volume (4 weeks):2,483,438
4 Weeks Range:3.94 - 6.09
4 Weeks Price Volatility (%):
6.51%
52 Weeks Range:2.92 - 12.22
52 Weeks Price Volatility (%):
12.47%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Bio-Path Holdings Inc is a US-based clinical and preclinical stage company. It focuses on oncology antisense drug development utilizing a novel technology. The company's drug delivery and antisense technology referred as DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by enzymes when circulating in vivo, incorporated inside of a neutrally charged lipid bilayer. The lead drug candidate of the company is prexigebersen which is a nonproprietary drug for acute myeloid leukemia as well as solid tumors, including breast cancer and ovarian cancer. Its other drug candidate is Liposomal Bcl2 which targets the protein Bcl2, which is responsible for driving cell proliferation of all cancers.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2228  6332  529  166 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 41.27-1.90 
 DSS 6.82+2.78 
 AAPL 115.05+0.01 
 GE 7.38-0.25 
 SPY 339.39-6.39 
 AAL 11.80-0.80 
 SQQQ 22.58+0.98 
 GRIL 2.04+0.51 
 OAS 0.155-0.014 
 NIO 26.01-1.15